Compare Charles River Laboratories Intl. Inc (CRL) vs General Motors Company (GM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs General Motors Company — how do they compare? Charles River Laboratories Intl. Inc trades at $302.17 (market cap $14.23B), while General Motors Company trades at $82.74 (market cap $72.17B). The key difference: General Motors Company is far larger — about 5.1× Charles River Laboratories Intl. Inc's market cap, and General Motors Company pays a 0.88% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and General Motors Company for 83 Days on average.
| CRL | GM | |
|---|---|---|
Market Cap | $14.23B | $72.17B |
Volume | 1,176,885 | 4,900,304 |
Sector | Health | Consumer Cyclical |
52-Week High | $310.77 | $90.30 |
52-Week Low | $149.93 | $55.35 |
Typical Hold Time | 33 Days | 83 Days |
Enterprise Value | $17.06B | $175.15B |
Dividend Yield | — | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRL trades at $304.01, up 1.24% on the day, near the consensus price target of $305.50. The stock shows a bullish technical trend with strong analyst support (73% buy ratings) and has beaten EPS estimates for three consecutive quarters. However, fundamentals reveal challenges with negative net income margins and a high P/E ratio of 684.85, while recent news highlights a strategic growth plan targeting 5-7% revenue growth and $300 million in savings by 2030.
The outlook is cautiously optimistic given strong analyst sentiment and recent earnings beats, but high valuation and profitability concerns pose risks. Investment opportunity hinges on successful execution of the new growth strategy to improve margins, while key risks include persistent negative earnings, competitive pressures, and execution missteps in achieving long-term targets.
General Motors (GM) trades at $82.73, up 2.15% with a bearish technical signal despite recent earnings beats. The company shows mixed fundamentals with strong operating cash flow of $26.87B in 2025 but declining profit margins. Recent Q3 2026 sales fell 5.5% as EV demand weakens and Toyota challenges GM's U.S. sales leadership. Analyst consensus remains bullish with a $102.08 price target, though technical indicators show resistance at $83-$85 levels.
GM faces near-term headwinds from declining vehicle sales and margin pressure, but cost savings from eased fuel economy rules ($20.4B through 2031) and strong cash generation provide stability. The stock trades at attractive valuations (P/S 0.42) with 67% analyst buy ratings, though competitive threats and EV transition challenges require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →
